Join
Live feed
·
INSIDERFilingvia Quantisnow
Scopus BioPharma Inc. logo

SEC Form 4: R Joshua Lamstein bought $4,670 worth of Common Stock (500 units at $9.34), increasing ownership by 0.43% to 117,297 units

ByQuantisnow·Wall Street's wire, on your screen.
SCPS· Scopus BioPharma Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SCPS (Scopus BioPharma Inc.) and more on Quantisnow.